Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: A cross-sectional analysis
Creators
- Ballard, April M.1
- Falk, Dylan1
- Greenwood, Harris1
- Gugerty, Paige1
- Feinberg, Judith2
- Friedmann, Peter D.3
- Go, Vivian F.4
- Jenkins, Wiley D.5
- Korthuis, P. Todd6
- Miller, William C.7
- Pho, Mai T.8
- Seal, David W.9
- Smith, Gordon S.2
- Stopka, Thomas J.10
- Westergaard, Ryan P.11
- Zule, William A.12
- Young, April M.13
- Cooper, Hannah L. F.1
- 1. Emory University
- 2. West Virginia University
- 3. University of Massachusetts
- 4. University of North Carolina, Chapel Hill
- 5. Southern Illinois University
- 6. Oregon Health & Science University
- 7. The Ohio State University
- 8. University of Chicago
- 9. Tulane University
- 10. Tufts University
- 11. University of Wisconsin-Madison
- 12. RTI International
- 13. University of Kentucky
Description
Background: Research conducted in urban areas has highlighted the impact of housing instability on people who inject drugs (PWID), revealing that it exacerbates vulnerability to drug-related harms and impedes syringe service program (SSP) use. However, few studies have explored the effects of houselessness on SSP use among rural PWID. This study examines the relationship between houselessness and SSP utilization among PWID in eight rural areas across 10 states.
Methods: PWID were recruited using respondent-driven sampling for a cross-sectional survey that queried self-reported drug use and SSP utilization in the prior 30 days, houselessness in the prior 6 months and sociodemographic characteristics. Using binomial logistic regression, we examined the relationship between experiencing houselessness and any SSP use. To assess the relationship between houselessness and the frequency of SSP use, we conducted multinomial logistic regression analyses among participants reporting any past 30-day SSP use.
Results: Among 2394 rural PWID, 56.5% had experienced houselessness in the prior 6 months, and 43.5% reported past 30-day SSP use. PWID who had experienced houselessness were more likely to report using an SSP compared to their housed counterparts (adjusted odds ratio [aOR] = 1.24 [95% confidence intervals [CI] 1.01, 1.52]). Among those who had used an SSP at least once (n = 972), those who experienced houselessness were just as likely to report SSP use two (aOR = 0.90 [95% CI 0.60, 1.36]) and three times (aOR = 1.18 [95% CI 0.77, 1.98]) compared to once. However, they were less likely to visit an SSP four or more times compared to once in the prior 30 days (aOR = 0.59 [95% CI 0.40, 0.85]).
Conclusion: This study provides evidence that rural PWID who experience houselessness utilize SSPs at similar or higher rates as their housed counterparts. However, housing instability may pose barriers to more frequent SSP use. These findings are significant as people who experience houselessness are at increased risk for drug-related harms and encounter additional challenges when attempting to access SSPs.
Data availability
We welcome collaboration and encourage mentorship and the use of ROI data stripped of all protected health information (PHI) to enable early investigators to address meaningful questions with support to help ensure their success. Additional information can be obtained at the ROI website: ruralopioidinitiative.org or by contacting the ROI DCC. Follow the Rural Opioid Initiative on Twitter @ruralopioids.Files
Houselessness-and-syringe-service-program-utilization.pdf
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:ef4f7f403cb763963d6c0de83209c490
|
31.1 kB | Download |
|
Article md5:e77261c5f6c6a6a8714c3e1f8b858edd |
1.3 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1186/s12954-023-00892-w
- Other
- oai:uchicago.tind.io:9292
Funding
- National Institute on Drug Abuse
- UG3DA044829/UH3DA044829
- National Institute on Drug Abuse
- UG3DA044798/UH3DA044798
- National Institute on Drug Abuse
- UG3DA044830/UH3DA044830
- National Institute on Drug Abuse
- UG3DA044823/UH3DA044823
- National Institute on Drug Abuse
- UG3DA044822/UH3DA044822
- National Institute on Drug Abuse
- UG3DA044831/UH3DA044831
- National Institute on Drug Abuse
- UG3DA044825
- National Institute on Drug Abuse
- UG3DA044826/UH3DA044826
- Centers for Disease Control and Prevention
- Substance Abuse and Mental Health Services Administration
- Appalachian Regional Commission
- National Institute on Drug Abuse
- U24DA048538